SCHEMBL14980756

SCHEMBL14980756

COc1ccc(OC[C@H](C)O)cc1N

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
MEN1 O00255 2/20 0.56
KMT2A Q03164 2/20 0.56
MAPT P10636 1/20 0.56
THRB P10828 1/20 0.56
CYP2C19 P33261 1/20 0.51
LMNA P02545 2/20 0.47
GAA P10253 1/20 0.46
CYP3A4 P08684 2/20 0.44
ADRA2A P08913 2/20 0.44
ADRA1A P35348 2/20 0.44
HTT P42858 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
CYP2D6 P10635 1/20 0.43
MAPK1 P28482 2/20 0.42
BLM P54132 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10631858 1.00 ALDH1A1 (0.56) ALDH1A1MEN1KMT2AMAPTTHRB
SCHEMBL10629670 0.90 CYP2C19 (0.61) ALDH1A1MEN1KMT2AMAPTTHRB
SCHEMBL10629322 0.87 CYP2C19 (0.58) ALDH1A1MEN1KMT2AMAPTTHRB
SCHEMBL21120353 0.87 ALDH1A1 (0.59) ALDH1A1MEN1KMT2AMAPTTHRB
SCHEMBL22426031 0.85 ALDH1A1 (0.58) ALDH1A1MEN1KMT2AMAPTTHRB
SCHEMBL20719974 0.85 CA12 (0.53) MEN1KMT2ALMNAADRA2AADRA1A
SCHEMBL10635852 0.84 KMT2A (0.53) ALDH1A1MEN1KMT2AMAPTTHRB
SCHEMBL2205133 0.81 HIF1A (0.58) ALDH1A1MEN1KMT2AMAPTTHRB
SCHEMBL10636013 0.81 KMT2A (0.49) ALDH1A1MEN1KMT2AMAPTTHRB
SCHEMBL12428893 0.81 KMT2A (0.49) ALDH1A1MEN1KMT2AMAPTTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2188292-B1 2- [ (2-{PHENYLAMINO}-1H-PYRROLO [2, 3-D]PYRIMIDIN-4-YL) AMINO]BENZAMIDE DERIVATIVES AS IGF-1R INHIBITORS FOR THE TREATMENT OF CANCER GLAXOSMITHKLINE IP DEV LTD (GB) 2013-05-29 EP disclosed